ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Inclusion Criteria * HIV-1 positive * antiretroviral-adult males * non-pregnant * non-lactating females at least 18-years old with plasma HIV-1 RNA \> 5000 copies/mL, who were not acutely ill Exclusion Criteria * History of: * prior antiretroviral therapy * significant drug hypersensitivity * psychiatric illness that precludes compliance * an active substance abuser * positive test results for drug abuse * abnormal lab test results (hemoglobin, absolute neutrophil count, platelet count, SGPT/AST or SGPT/ALT, creatinine, fasting triglycerides, significant abnormal ECG results * pregnancy or lactating female * received another investigational drug within 28 days of study initiation * unlikely to comply or unsuitable candidate in the opinion of the investigator